Pharmaceutical companies can use AI tools, but the rigour depends on what the AI is used for. Where it influences a regulated outcome, MHRA expectations point to defining its intended use, classifying the risk, controlling the data it relies on, validating it for that use, and keeping clear human oversight. For everyday productivity tasks, business-grade tools used with sensible rules are much lower risk. The key is to treat AI like any other system that touches regulated work.
AI can help with documentation, analysis and routine tasks, but in a regulated business it can’t be a black box making decisions no one can explain. Here is how to use it responsibly.
Separate regulated use from general productivity
There’s a big difference between AI summarising an internal email and AI influencing a quality or manufacturing decision. The first is low risk if handled sensibly. The second needs the full discipline of intended use, risk classification, validation and oversight. Be clear which is which before you adopt a tool.
Control the data AI can see
Keep confidential and regulated data out of free, public AI tools. Business-grade tools such as Microsoft 365 Copilot work within your existing environment and permissions, respecting who can see what and not using your data to train public models. Get your access controls tidy first, so AI can’t surface data a user shouldn’t see.
Validate AI that affects regulated outcomes
Where AI influences a GxP decision, it falls under the same expectations as other computerised systems: define what it’s meant to do, assess the risk, test that it does it, control changes, and keep the evidence. AI that updates over time needs particular thought, since a change in behaviour can affect a validated state.
Keep people in charge
AI can be confidently wrong, so a qualified person should review its output, especially anything affecting quality, safety or compliance. Responsibility for the decision stays with your people, not the tool.
A real example: a well-governed environment
We were closely involved in developing the business systems that helped a client grow from 20 users to 100 over five years. A well-run, well-governed environment is exactly what lets a regulated business adopt new tools like AI safely and on its own terms.
Why pharmaceutical businesses choose First Stop IT
First Stop IT has supported businesses since 2002 and is a Microsoft Partner. Our credentials include:
- Cyber Essentials Certified
- IASME Cyber Assurance (Gold)
- NCSC Assured Service Provider (Cyber Advisor for Cyber Essentials)
- Microsoft Partner
- Crown Commercial Service Supplier (G-Cloud)
- Quality Principles Certified
We look after more than 2,000 endpoints across 50 companies, we’ve been named a Top 50 UK MSP for three years running, and we support organisations with 10 to 100 employees across Essex and Hertfordshire.
Book a free Microsoft 365 and AI readiness review
Considering AI in a regulated business? Book a free IT and cyber security review with First Stop IT and we’ll check your environment is ready to use it safely.